Palo Alto Investors’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.9M | Buy |
3,429,329
+218,015
| +7% | +$375K | 1.26% | 19 |
|
|
2025
Q1 | $10.7M | Buy |
3,211,314
+169,629
| +6% | +$565K | 2.04% | 14 |
|
|
2024
Q4 | $22.5M | Hold |
3,041,685
| – | – | 3.49% | 11 |
|
|
2024
Q3 | $28.6M | Buy |
3,041,685
+925,282
| +44% | +$8.69M | 3.71% | 10 |
|
|
2024
Q2 | $17M | Buy |
2,116,403
+3,592
| +0.2% | +$28.8K | 1.97% | 12 |
|
|
2024
Q1 | $31.3M | Buy |
2,112,811
+6,019
| +0.3% | +$89.2K | 3.53% | 9 |
|
|
2023
Q4 | $17.1M | Buy |
+2,106,792
| New | +$17.1M | 1.54% | 14 |
|